Drug delivery companies and the products borne from them are often characterised by complex partnerships between companies, with licensing agreements and strategic relationships. The challenges they seek to face and overcome rely upon strong technology delivering drugs to targeted sites in the patient. Outsourcing of opportunities has dramatically increased over the last decade. As a […]
